HURN Q2 2026: Record Revenue, Elevated EPS, and a Higher 2026 Guiding Needle

Ticker: HURN (NYSE: HURN). In a quarter that reads like a well-structured balance sheet of confidence, HURN delivered stronger revenue growth, rising earnings per share, and a raised full-year outlook. This is the kind of release that invites a closer look at what the business is actually selling, where the demand is coming from, and how capital is being allocated in a sector that prizes visibility and discipline.

Executive snapshot

HURN reported a record second quarter 2026, with revenues before reimbursable expenses (RBR) of $465.6 million, a 15.7% year-over-year increase from $402.5 million in Q2 2025. Net income rose to $31.2 million in Q2 2026, versus $19.4 million in Q2 2025, noting that the prior-year period included an $8.2 million non-cash impairment charge related to a convertible debt investment. Diluted earnings per share (EPS) reached $1.91 in Q2 2026, up from $1.09 in the year-ago period, while adjusted diluted EPS expanded to $2.46 from $1.89. Adjusted EBITDA grew to $72.6 million, up from $60.6 million a year earlier.

Cash generation remained robust: net cash provided by operating activities rose to $120.5 million in Q2 2026, a meaningful increase from $80.0 million in Q2 2025. The company also returned capital to shareholders, repurchasing $53.1 million of stock (0.4 million shares) in the quarter, representing 2.5% of the outstanding stock as of December 31, 2025.

For the year-to-date frame, revenues before reimbursable expenses (RBR) totaled $909.3 million, up 13.9% versus the prior-year six months. Net income for the first six months of 2026 rose to $54.5 million, from $44.0 million in the same period of 2025, which included an $8.2 million impairment in the prior year.

Key metrics at a glance

RBR revenue, Q2 2026: $465.6 million (+15.7% YoY)
Net income, Q2 2026: $31.2 million
Diluted EPS, Q2 2026: $1.91 (vs. $1.09 in Q2 2025)
Adjusted diluted EPS, Q2 2026: $2.46 (vs. $1.89 in Q2 2025)
Adjusted EBITDA, Q2 2026: $72.6 million (vs. $60.6 million)
Net cash from operating activities, Q2 2026: $120.5 million
Share repurchases, Q2 2026: $53.1 million (0.4 million shares)
YTD 2026 RBR: $909.3 million (+13.9% YoY)
YTD 2026 net income: $54.5 million

What does this portend for HURN and the sector?

The quarter reads as a straightforward demonstration of demand resilience and operating leverage. A double-digit rise in RBR revenue, coupled with a material uplift in EPS—both diluted and adjusted—points to a steady drumbeat of client activity and pricing power. The impairment charge that weighed the prior year's comparison creates a non-trivial base effect; in plain terms, 2025’s headwind makes 2026 look even better in retrospective eyes. Still, the company’s ability to translate that top-line momentum into cash flow ($120.5 million in operating cash, for instance) and disciplined capital allocation (a $53.1 million buyback in the quarter) signals a management team that is comfortable deploying capital where it believes it can create value.

The new guidance for 2026 is the key ignition switch here. While the press release notes a higher outlook, the specifics aren’t laid out in the excerpt provided. The combination of revenue growth, margin-friendly mix, and cash returns often acts as a multiplier for multiple expansion in stock valuations, particularly in professional services where visibility on project win rates and client budgets remains a central determinant of earnings tempo.

In the broader sector context, peers with similar client profiles—especially in healthcare and specialized advisory segments—may take note. If HURN’s demand catalysts persist (broader healthcare spending, ongoing regulatory-driven transformations, and continued demand for high-margin advisory services), we could see a tightening of risk premia for high-quality, cash-generative services firms. The emphasis on non-GAAP metrics like Adjusted EBITDA and Adjusted diluted EPS reinforces the market’s appetite for metrics that strip away one-off noise, but the year-over-year improvement and positive cash flow punch are hard to ignore in any EBITDA-centric discussion.

Outlook for the sector and implications for peers

The raised 2026 guidance, coupled with a record quarterly print, may heighten expectations for other firms with similar business models. Analysts watching EPS consensus and revenue forecasts will likely test whether Q2’s strength can sustain into the back half of the year. For HURN itself, the combination of robust cash generation and a balanced capital allocation program—reinvesting in growth while returning capital—sets a template that peers might emulate, particularly in how they communicate guidance and route capital after a period of revenue ramp.

On a macro note, the market often treats earnings announcements as a narrative about demand durability. If the sector’s buyers continue to allocate budgets toward strategic initiatives and digital transformation, the earnings surprise potential could skew to the upside. Conversely, any deceleration in large, long-cycle engagements could test the resilience of these earnings trajectories. Investors should watch how the company follows up this quarter with sustained revenue momentum, margin discipline, and the pace of buybacks relative to free cash flow generation.

Bottom line and takeaways

HURN’s Q2 2026 results deliver a credible story of growth: stronger revenue, higher EPS (both reported and adjusted), and meaningful free cash flow, all while returning capital to shareholders. The decision to raise guidance hints at management’s confidence in continued demand and operational execution. For investors and sector peers, the takeaway is not merely the magnitude of the numbers, but the signaling about execution discipline, capital allocation, and the ability to translate top-line strength into durable earnings growth.